Annual Total Debt
$10.01 M
+$4.69 M+88.13%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual total debt is $10.01 million, with the most recent change of +$4.69 million (+88.13%) on April 30, 2024.
- During the last 3 years, IPA annual total debt has risen by +$7.19 million (+255.48%).
- IPA annual total debt is now at all-time high.
Performance
IPA Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$11.81 M
+$183.80 K+1.58%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly total debt is $11.81 million, with the most recent change of +$183.80 thousand (+1.58%) on October 31, 2024.
- Over the past year, IPA quarterly total debt has increased by +$183.80 thousand (+1.58%).
- IPA quarterly total debt is now at all-time high.
Performance
IPA Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
IPA Total Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +88.1% | +1.6% |
3 y3 years | +255.5% | +1.6% |
5 y5 years | +360.2% | +1.6% |
IPA Total Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +368.2% | at high | +1261.7% |
5 y | 5-year | at high | +368.2% | at high | +1261.7% |
alltime | all time | at high | -100.0% | at high | -100.0% |
ImmunoPrecise Antibodies Total Debt History
Date | Annual | Quarterly |
---|---|---|
Oct 2024 | - | $11.81 M(+1.6%) |
Jul 2024 | - | $11.62 M(+16.1%) |
Apr 2024 | $10.01 M(+88.1%) | $10.01 M(-6.8%) |
Jan 2024 | - | $10.74 M(+55.1%) |
Oct 2023 | - | $6.92 M(-6.5%) |
Jul 2023 | - | $7.40 M(+39.2%) |
Apr 2023 | $5.32 M(+148.9%) | $5.32 M(-4.7%) |
Jan 2023 | - | $5.58 M(+13.7%) |
Oct 2022 | - | $4.91 M(+466.5%) |
Jul 2022 | - | $867.10 K(-59.4%) |
Apr 2022 | $2.14 M(-24.1%) | $2.14 M(-3.0%) |
Jan 2022 | - | $2.21 M(-6.7%) |
Oct 2021 | - | $2.36 M(-10.3%) |
Jul 2021 | - | $2.64 M(-6.4%) |
Apr 2021 | $2.82 M(-12.6%) | $2.82 M(-1.9%) |
Jan 2021 | - | $2.87 M(-10.4%) |
Oct 2020 | - | $3.20 M(-14.5%) |
Jul 2020 | - | $3.75 M(+16.3%) |
Apr 2020 | $3.22 M(+48.1%) | $3.22 M(+2.4%) |
Jan 2020 | - | $3.14 M(-6.7%) |
Oct 2019 | - | $3.37 M(-4.0%) |
Jul 2019 | - | $3.51 M(+61.5%) |
Apr 2019 | $2.18 M(-27.0%) | $2.18 M(+0.2%) |
Jan 2019 | - | $2.17 M(+3.3%) |
Oct 2018 | - | $2.10 M(-33.1%) |
Jul 2018 | - | $3.14 M(+5.4%) |
Apr 2018 | $2.98 M(>+9900.0%) | $2.98 M(>+9900.0%) |
Jan 2018 | - | $0.00(0.0%) |
Oct 2017 | - | $0.00(0.0%) |
Jul 2017 | - | $0.00(0.0%) |
Apr 2017 | $0.00(-100.0%) | $0.00(-100.0%) |
Jan 2017 | - | $70.40 K(+70.5%) |
Sep 2016 | - | $41.30 K(-28.5%) |
Jun 2016 | - | $57.80 K(+0.3%) |
Mar 2016 | - | $57.60 K(+6.9%) |
Dec 2015 | $53.90 K(-15.4%) | - |
Dec 2015 | - | $53.90 K(-2.2%) |
Sep 2015 | - | $55.10 K(-7.6%) |
Jun 2015 | - | $59.60 K(+2.2%) |
Mar 2015 | - | $58.30 K(-8.5%) |
Dec 2014 | $63.70 K(-44.8%) | - |
Dec 2014 | - | $63.70 K(-2.5%) |
Sep 2014 | - | $65.30 K(-43.3%) |
Jun 2014 | - | $115.20 K(+3.6%) |
Mar 2014 | - | $111.20 K(-3.6%) |
Dec 2013 | $115.40 K(+129.4%) | - |
Dec 2013 | - | $115.40 K(+35.3%) |
Sep 2013 | - | $85.30 K(+1.5%) |
Jun 2013 | - | $84.00 K(-3.0%) |
Mar 2013 | - | $86.60 K(+72.2%) |
Dec 2012 | $50.30 K(+2.7%) | - |
Dec 2012 | - | $50.30 K(>+9900.0%) |
Sep 2012 | - | $0.00(0.0%) |
Jun 2012 | - | $0.00(0.0%) |
Mar 2012 | - | $0.00(-100.0%) |
Dec 2011 | $49.00 K(>+9900.0%) | - |
Dec 2011 | - | $49.00 K(>+9900.0%) |
Sep 2011 | - | $0.00(0.0%) |
Jun 2011 | - | $0.00(0.0%) |
Mar 2011 | - | $0.00(0.0%) |
Dec 2010 | $0.00(0.0%) | - |
Dec 2010 | - | $0.00(0.0%) |
Sep 2010 | - | $0.00(0.0%) |
Jun 2010 | - | $0.00(0.0%) |
Mar 2010 | - | $0.00 |
Date | Annual | Quarterly |
---|---|---|
Dec 2009 | $0.00(0.0%) | - |
Dec 2009 | - | $0.00(0.0%) |
Sep 2009 | - | $0.00(0.0%) |
Jun 2009 | - | $0.00(0.0%) |
Mar 2009 | - | $0.00(0.0%) |
Dec 2008 | $0.00(0.0%) | - |
Dec 2008 | - | $0.00(0.0%) |
Sep 2008 | - | $0.00(0.0%) |
Jun 2008 | - | $0.00(0.0%) |
Mar 2008 | - | $0.00(0.0%) |
Dec 2007 | $0.00(0.0%) | - |
Dec 2007 | - | $0.00(0.0%) |
Sep 2007 | - | $0.00(0.0%) |
Jun 2007 | - | $0.00(0.0%) |
Mar 2007 | - | $0.00(0.0%) |
Dec 2006 | $0.00(0.0%) | - |
Dec 2006 | - | $0.00(0.0%) |
Sep 2006 | - | $0.00(0.0%) |
Jun 2006 | - | $0.00(0.0%) |
Mar 2006 | - | $0.00(0.0%) |
Dec 2005 | $0.00(0.0%) | - |
Dec 2005 | - | $0.00(0.0%) |
Sep 2005 | - | $0.00(0.0%) |
Jun 2005 | - | $0.00(0.0%) |
Mar 2005 | - | $0.00(0.0%) |
Dec 2004 | $0.00(0.0%) | - |
Dec 2004 | - | $0.00(0.0%) |
Sep 2004 | - | $0.00(0.0%) |
Jun 2004 | - | $0.00(0.0%) |
Mar 2004 | - | $0.00(0.0%) |
Dec 2003 | $0.00(-100.0%) | - |
Dec 2003 | - | $0.00(0.0%) |
Sep 2003 | - | $0.00(0.0%) |
Jun 2003 | - | $0.00(-100.0%) |
Mar 2003 | - | $5100.00(+6.3%) |
Dec 2002 | $4800.00(>+9900.0%) | - |
Dec 2002 | - | $4800.00(>+9900.0%) |
Sep 2002 | - | $0.00(0.0%) |
Jun 2002 | - | $0.00(0.0%) |
Mar 2002 | - | $0.00(0.0%) |
Dec 2001 | $0.00(0.0%) | - |
Dec 2001 | - | $0.00(0.0%) |
Sep 2001 | - | $0.00(0.0%) |
Jun 2001 | - | $0.00(0.0%) |
Mar 2001 | - | $0.00(0.0%) |
Dec 2000 | $0.00(0.0%) | - |
Dec 2000 | - | $0.00(0.0%) |
Sep 2000 | - | $0.00(0.0%) |
Jun 2000 | - | $0.00(0.0%) |
Mar 2000 | - | $0.00(0.0%) |
Dec 1999 | $0.00(0.0%) | - |
Dec 1999 | - | $0.00(0.0%) |
Sep 1999 | - | $0.00(0.0%) |
Jun 1999 | - | $0.00(0.0%) |
Mar 1999 | - | $0.00(0.0%) |
Dec 1998 | $0.00(0.0%) | - |
Dec 1998 | - | $0.00(0.0%) |
Sep 1998 | - | $0.00(0.0%) |
Jun 1998 | - | $0.00(0.0%) |
Mar 1998 | - | $0.00(0.0%) |
Dec 1997 | $0.00(0.0%) | - |
Dec 1997 | - | $0.00(0.0%) |
Sep 1997 | - | $0.00(0.0%) |
Jun 1997 | - | $0.00(0.0%) |
Mar 1997 | - | $0.00 |
Dec 1996 | $0.00 | - |
FAQ
- What is ImmunoPrecise Antibodies annual total debt?
- What is the all time high annual total debt for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual total debt year-on-year change?
- What is ImmunoPrecise Antibodies quarterly total debt?
- What is the all time high quarterly total debt for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly total debt year-on-year change?
What is ImmunoPrecise Antibodies annual total debt?
The current annual total debt of IPA is $10.01 M
What is the all time high annual total debt for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual total debt is $10.01 M
What is ImmunoPrecise Antibodies annual total debt year-on-year change?
Over the past year, IPA annual total debt has changed by +$4.69 M (+88.13%)
What is ImmunoPrecise Antibodies quarterly total debt?
The current quarterly total debt of IPA is $11.81 M
What is the all time high quarterly total debt for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly total debt is $11.81 M
What is ImmunoPrecise Antibodies quarterly total debt year-on-year change?
Over the past year, IPA quarterly total debt has changed by +$183.80 K (+1.58%)